Long COVID long COVID herbal supplement lime bamboo grass cannabis galangal pepper
Conditions
Interventions
Clears-belong Plus is a herbal dietary supplement containing powders of lime, bamboo grass, cannabis, galangal, and pepper (registration no. 13-2-10660-5-0002). One capsule contains 500 mg. Participan
Experimental Dietary Supplement,Placebo Comparator No treatment
Clears-belong Plus,Placebo
Sponsors
Rangsit University
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Thai males and females aged 20 years old or above. 2. Previously had COVID-19 infection as confirmed by ATK or RT-PCR at least 4 weeks before screening. 3. Long COVID diagnosis as confirmed by a physician. 4. Willing to attend all the study procedures.
Exclusion criteria
Exclusion criteria: 1. Have or suspected to have penumonitis 2. Have at least one of the following conditions: chronic obstructive pulmonary disease, chronic lung diseases, chronic renal disease, cardiovascular diseases, cerebrovascular diseases, congenital heart diseases, psychotic disorders, hepatitis, cirrhosis, and immunodeficiency disorders 3. Current use of warfarin or benzodiazepines 4. Positive result from tetrahydrocannabinol (THC) urine test at screening 5. Positive result from urine pregnancy test at screening 6. Plan to become pregnant or breastfeeding 7. History of hypersensitivity to any active ingredients of Clears-belong Plus 8. Participating in other studies 9. Any other health conditions that could interfere with participation in this study based on investigator's judgement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom severity at baseline and end of treatment questionnaire,C-reactive protein level at baseline and end of treatment blood sampling | — |
Secondary
| Measure | Time frame |
|---|---|
| Full recovery and long COVID symptom improvement at baseline and end of treatment questionnaire,Quality of life at baseline and end of treatment questionnaire,Adverse events after randomization through end of study collection of adverse events by investigators | — |
Countries
Thailand
Contacts
Public ContactThitiya Lukkunaprasit
Rangsit University
Outcome results
None listed